Literature DB >> 31248555

Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel.

Costantino Iadecola1, Marco Duering2, Vladimir Hachinski3, Anne Joutel4, Sarah T Pendlebury5, Julie A Schneider6, Martin Dichgans7.   

Abstract

Cognitive impairment associated with aging has emerged as one of the major public health challenges of our time. Although Alzheimer's disease is the leading cause of clinically diagnosed dementia in Western countries, cognitive impairment of vascular etiology is the second most common cause and may be the predominant one in East Asia. Furthermore, alterations of the large and small cerebral vasculature, including those affecting the microcirculation of the subcortical white matter, are key contributors to the clinical expression of cognitive dysfunction caused by other pathologies, including Alzheimer's disease. This scientific expert panel provides a critical appraisal of the epidemiology, pathobiology, neuropathology, and neuroimaging of vascular cognitive impairment and dementia, and of current diagnostic and therapeutic approaches. Unresolved issues are also examined to shed light on new basic and clinical research avenues that may lead to mitigating one of the most devastating human conditions.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; cerebral blood flow; cognitive dysfunction; small vessel disease; stroke

Year:  2019        PMID: 31248555      PMCID: PMC6719789          DOI: 10.1016/j.jacc.2019.04.034

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  130 in total

1.  Cerebral blood flow in dementia.

Authors:  V C Hachinski; L D Iliff; E Zilhka; G H Du Boulay; V L McAllister; J Marshall; R W Russell; L Symon
Journal:  Arch Neurol       Date:  1975-09

Review 2.  Neurovascular regulation in the normal brain and in Alzheimer's disease.

Authors:  Costantino Iadecola
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

3.  Relation of cerebral infarctions to dementia and cognitive function in older persons.

Authors:  J A Schneider; R S Wilson; E J Cochran; J L Bienias; S E Arnold; D A Evans; D A Bennett
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

4.  Progression of impairment in patients with vascular cognitive impairment without dementia.

Authors:  C Wentzel; K Rockwood; C MacKnight; V Hachinski; D B Hogan; H Feldman; T Østbye; C Wolfson; S Gauthier; R Verreault; I McDowell
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

5.  Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  A Lobo; L J Launer; L Fratiglioni; K Andersen; A Di Carlo; M M Breteler; J R Copeland; J F Dartigues; C Jagger; J Martinez-Lage; H Soininen; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

6.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

Authors:  James Shepherd; Gerard J Blauw; Michael B Murphy; Edward L E M Bollen; Brendan M Buckley; Stuart M Cobbe; Ian Ford; Allan Gaw; Michael Hyland; J Wouter Jukema; Adriaan M Kamper; Peter W Macfarlane; A Edo Meinders; John Norrie; Chris J Packard; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

Review 7.  Differentiation of vascular dementia from AD on neuropsychological tests.

Authors:  J C Looi; P S Sachdev
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

Review 8.  White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease.

Authors:  R Schmidt; Ph Scheltens; T Erkinjuntti; L Pantoni; H S Markus; A Wallin; F Barkhof; F Fazekas
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

9.  Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.

Authors:  Christophe Tzourio; Craig Anderson; Neil Chapman; Mark Woodward; Bruce Neal; Stephen MacMahon; John Chalmers
Journal:  Arch Intern Med       Date:  2003-05-12

10.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

View more
  97 in total

1.  IGF1R signaling regulates astrocyte-mediated neurovascular coupling in mice: implications for brain aging.

Authors:  Stefano Tarantini; Priya Balasubramanian; Andriy Yabluchanskiy; Nicole M Ashpole; Sreemathi Logan; Tamas Kiss; Anna Ungvari; Ádám Nyúl-Tóth; Michal L Schwartzman; Zoltan Benyo; William E Sonntag; Anna Csiszar; Zoltan Ungvari
Journal:  Geroscience       Date:  2021-03-06       Impact factor: 7.713

2.  Blood Pressure Ups and Downs Foreshadow Cerebral Microangiopathy.

Authors:  Costantino Iadecola; Neal S Parikh
Journal:  J Am Coll Cardiol       Date:  2020-05-19       Impact factor: 24.094

Review 3.  Potential of Glucagon-Like Peptide 1 as a Regulator of Impaired Cholesterol Metabolism in the Brain.

Authors:  Young-Kook Kim; Juhyun Song
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

4.  Apelin inhibits an endothelium-derived hyperpolarizing factor-like pathway in rat cerebral arteries.

Authors:  Amreen Mughal; Santo Anto; Chengwen Sun; Stephen T O'Rourke
Journal:  Peptides       Date:  2020-06-21       Impact factor: 3.750

5.  Framingham General Cardiovascular Risk Score and Cognitive Impairment: The Power of Foresight.

Authors:  Costantino Iadecola; Neal S Parikh
Journal:  J Am Coll Cardiol       Date:  2020-05-26       Impact factor: 24.094

6.  HB-EGF depolarizes hippocampal arterioles to restore myogenic tone in a genetic model of small vessel disease.

Authors:  Jackson T Fontaine; Amanda C Rosehart; Anne Joutel; Fabrice Dabertrand
Journal:  Mech Ageing Dev       Date:  2020-10-27       Impact factor: 5.432

Review 7.  Immune responses to stroke: mechanisms, modulation, and therapeutic potential.

Authors:  Costantino Iadecola; Marion S Buckwalter; Josef Anrather
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

8.  Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol.

Authors:  Marios K Georgakis; Rainer Malik; Christopher D Anderson; Klaus G Parhofer; Jemma C Hopewell; Martin Dichgans
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

Review 9.  Pathological Continuum From the Rise in Pulse Pressure to Impaired Neurovascular Coupling and Cognitive Decline.

Authors:  Olivia de Montgolfier; Nathalie Thorin-Trescases; Eric Thorin
Journal:  Am J Hypertens       Date:  2020-04-29       Impact factor: 2.689

10.  Diffuse white matter loss in a transgenic rat model of cerebral amyloid angiopathy.

Authors:  Hedok Lee; Feng Xu; Xiaodan Liu; Sunil Koundal; Xiaoyue Zhu; Judianne Davis; David Yanez; Joseph Schrader; Aleksandra Stanisavljevic; Douglas L Rothman; Joanna Wardlaw; William E Van Nostrand; Helene Benveniste
Journal:  J Cereb Blood Flow Metab       Date:  2020-08-13       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.